© 2002 European Society of Cardiology
Leukemia inhibitory factor is augmented in the heart in experimental heart failure
a Institute for Clinical Research, National Hospital Kyushu Cardiovascular Center 8-1 Shiroyama-cho, Kagoshima 892-0853, Japan
b Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Foundation Rochester, MN, USA
* Corresponding author. Tel.: +81-99-223-1151; fax: +81-99-226-9246 E-mail address: michi{at}qjun.hosp.go.jp
 |
Abstract |
|---|
Leukemia inhibitory factor (LIF) is a pleiotropic cytokine that induces cardiac myocyte hypertrophy through the signal transducing molecule, glycoprotein 130. To date, localization of LIF in the heart and regulation of cardiac LIF expression in congestive heart failure (CHF) remain undefined. The present study investigates the potential activation of LIF expression in the failing canine heart that was produced by progressive rapid ventricular pacing. Immunohistochemistry for LIF revealed that LIF immunoreactivity was present in the atrial and ventricular myocytes of the normal heart and was markedly increased in the failing heart as compared to the normal heart. Northern blot analysis demonstrated that cardiac LIF mRNA was increased in both atrium and ventricle in CHF as compared to the normal heart (P<0.01). Linear regression analysis revealed a positive correlation between atrial LIF mRNA and atrial pressure (r=0.87, P<0.001 in right atrium and r=0.86, P<0.001 in left atrium). Positive correlations between left ventricular LIF mRNA and left ventricular dimensions (r=0.91, P<0.0001 in end-systolic diameter; r=0.86, P<0.001 in end-diastolic diameter), and an inverse correlation between left ventricular LIF mRNA and left ventricular ejection fraction (EF) were observed (r=–0.93, P<0.0001). There was a positive correlation between left ventricular LIF mRNA and left ventricular mass index (LVMI) (r=0.85, P<0.001). The present study demonstrates that cardiac LIF immunoreactivity and its gene expression are increased in a canine model of experimental CHF and suggests a potential role for LIF in the pathophysiology of CHF.
Key Words: Cytokines • Gene expression • Heart failure • Congestive • Immunohistochemistry • Northern blot analysis
Received December 21, 2001; Revised June 18, 2002; Accepted October 18, 2002
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Princen, E. Bard, F. Sheikh, S. S. Zhang, J. Wang, W. M. Zago, D. Wu, R. D. Trelles, B. Bailly-Maitre, C. R. Kahn, et al. Deletion of Shp2 Tyrosine Phosphatase in Muscle Leads to Dilated Cardiomyopathy, Insulin Resistance, and Premature Death Mol. Cell. Biol., January 15, 2009; 29(2): 378 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Mohri, Y. Fujio, M. Maeda, T. Ito, T. Iwakura, Y. Oshima, Y. Uozumi, M. Segawa, H. Yamamoto, T. Kishimoto, et al. Leukemia Inhibitory Factor Induces Endothelial Differentiation in Cardiac Stem Cells J. Biol. Chem., March 10, 2006; 281(10): 6442 - 6447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tomita, M. Dragoman, H. Worcester, P. Conran, and T. J. Santoro Proinflammatory Cytokine Genes Are Constitutively Overexpressed in the Heart in Experimental Systemic Lupus Erythematosus: A Brief Communication Exp Biol Med, October 1, 2004; 229(9): 971 - 976. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. P.M van Empel and L. J De Windt Myocyte hypertrophy and apoptosis: a balancing act Cardiovasc Res, August 15, 2004; 63(3): 487 - 499. [Abstract] [Full Text] [PDF]
|
|